CANDACE NESMITH: Open Payments
NPI 1992275549 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,505 in 97 payments from 37 companies in 2025. Trend: 2023 $199 · 2024 $1,315 · 2025 $2,505
Food & beverage: $2,230Education: $275
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $284 |
| Janssen Biotech, Inc. | 6 | $196 |
| Incyte Corporation | 4 | $161 |
| Exelixis Inc. | 3 | $139 |
| Novartis Pharmaceuticals Corporation | 5 | $137 |
| Daiichi Sankyo Inc. | 5 | $121 |
| Genentech USA, Inc. | 6 | $120 |
| Merck Sharp & Dohme LLC | 5 | $117 |
| GlaxoSmithKline, LLC. | 6 | $115 |
| ABBVIE INC. | 5 | $107 |
Products named: ENHERTU, DARZALEX, KISQALI, KEYTRUDA, ZEPZELCA, LYNPARZA, VENCLEXTA, OJJAARA.
Industry payments across GA — which companies pay providers there.
